Literature DB >> 1473147

Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion.

E Reichmann1, H Schwarz, E M Deiner, I Leitner, M Eilers, J Berger, M Busslinger, H Beug.   

Abstract

As a novel approach to studying the modulation of the polarized epithelial phenotype, we have expressed c-Fos and c-Myc estrogen receptor fusion proteins (c-FosER and c-MycER) in mammary epithelial cells. The hybrid proteins could be activated by estrogen for defined time periods and after the cells had achieved their fully polarized organization. Activation of c-MycER deregulated proliferation but did not affect epithelial polarity. Short-term activation of c-FosER induced the reversible loss of morphological and functional cell polarity. In contrast, long-term stimulation of c-FosER caused the cells to depolarize irreversibly, to invade collagen gels, and to undergo epithelial-fibroblastoid cell conversion. Our data suggest that Fos proteins are important in modulating the epithelial phenotype both in normal tissue development and in invasive processes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1473147     DOI: 10.1016/s0092-8674(05)80060-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  85 in total

1.  CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase.

Authors:  E Vigo; H Müller; E Prosperini; G Hateboer; P Cartwright; M C Moroni; K Helin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Induced expression of Rnd3 is associated with transformation of polarized epithelial cells by the Raf-MEK-extracellular signal-regulated kinase pathway.

Authors:  S H Hansen; M M Zegers; M Woodrow; P Rodriguez-Viciana; P Chardin; K E Mostov; M McMahon
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.

Authors:  D L Crowe; T N Brown
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

4.  Mammary ductal growth is impaired in mice lacking leptin-dependent signal transducer and activator of transcription 3 signaling.

Authors:  Stephanie R Thorn; Sarah L Giesy; Martin G Myers; Yves R Boisclair
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

Review 5.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

6.  Critical regulation of genes for tumor cell migration by AP-1.

Authors:  El Mustapha Bahassi; Saikumar Karyala; Craig R Tomlinson; Maureen A Sartor; Mario Medvedovic; Robert F Hennigan
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

7.  AP-1 differentially expressed proteins Krp1 and fibronectin cooperatively enhance Rho-ROCK-independent mesenchymal invasion by altering the function, localization, and activity of nondifferentially expressed proteins.

Authors:  Heather J Spence; Lynn McGarry; Catherine S Chew; Neil O Carragher; Linda A Scott-Carragher; Zhengqiang Yuan; Daniel R Croft; Michael F Olson; Margaret Frame; Bradford W Ozanne
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

8.  Three-dimensional cultures of mouse mammary epithelial cells.

Authors:  Rana Mroue; Mina J Bissell
Journal:  Methods Mol Biol       Date:  2013

9.  A role for Syndecan-4 in neural induction involving ERK- and PKC-dependent pathways.

Authors:  Sei Kuriyama; Roberto Mayor
Journal:  Development       Date:  2009-01-14       Impact factor: 6.868

10.  Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation.

Authors:  Hong-Gyum Kim; Ki Won Lee; Yong-Yeon Cho; Nam Joo Kang; Sang-Muk Oh; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.